<DOC>
	<DOCNO>NCT01559220</DOCNO>
	<brief_summary>The purpose clinical study investigate safety efficacy deep brain stimulation ( DBS ) treatment option patient cognitive , behavioral , functional disability Alzheimer 's disease .</brief_summary>
	<brief_title>Deep Brain Stimulation Treatment Alzheimer 's Disease</brief_title>
	<detailed_description>Open label pilot study - Expected direct benefit modulation neuronal network . - Expected indirect benefit via potential enhancement memory , executive function , cognition behavioral control , functional ability . Up 10 subject implanted bilateral DBS system , participant expect study 23 month . - Develop multidisciplinary clinical research protocol evaluate efficacy ventral striatum , nucleus accumbens , internal capsule amelioration disability cause Alzheimer 's Disease . - Enroll 10 patient open label study evaluate safety efficacy DBS Alzheimer 's Disease patient mild moderate disability . - Determine initial DBS titration stimulation setting protocol use subsequent control trial . - Evaluate outcome study base clinical , laboratory , biomarker , imaging , cognitive , behavioral , functional assessment . - Determine domains cognitive , behavioral function impairment show great response DBS . - Examine potential benefit stimulation combine behavioral rehabilitation intervention comparison stimulation alone . - Evaluate influence DBS physiological functional change cortical subcortical network .</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Diagnosis probable AD accord National Institute Neurological Communicative Disorders StrokeAlzheimer 's Disease Related Disorders Association ( NINCDSADRDA ) criterion Has significant neurological disease , Alzheimer 's disease , e.g. , multiple sclerosis , Parkinson 's disease ischemic stroke , severe brain atrophy presence subdural hygromas subdural hematoma . Evidence substance abuse ( alcohol drug ) abuse dependence previous 12 month ( DSMIV Criteria ) .</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>